FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015270312> ?p ?o ?g. }

• W3015270312 endingPage "50" @default.
• W3015270312 startingPage "45" @default.
• W3015270312 abstract "CD19 is a type I transmembrane glycoprotein belonging to the immunoglobulin superfamily. It is expressed in normal and neoplastic B cells, and it modulates the threshold of B cell activation for amplifying B cell receptor signaling. Blinatumomab (a CD3–CD19-bispecific T cell-engaging antibody) and tisagenlecleucel (genetically modified T cells that express a CD19 chimeric antigen receptor [CART-19]) provide significant benefits for patients with CD19-positive relapsed or refractory B cell malignancies. In this study, we first employed the Cell-Based Immunization and Screening (CBIS) method to produce anti-CD19 monoclonal antibodies using CD19-overexpressing cells for both immunization and screening. One established clone—C19Mab-1—proved to be useful in flow cytometry assays against lymphoma cell lines, such as BALL-1, P30/OHK, and Raji. Second, the extracellular domain of CD19 was immunized into mice, and enzyme-linked immunosorbent assays were performed for the first screening. One established clone—C19Mab-3—was determined to be useful for Western blotting and immunohistochemical analysis. Due to their complementary utility, a combination of C19Mab-1 (established using CBIS) and C19Mab-3 (established using conventional method) could be useful for the pathological analysis of CD19." @default.
• W3015270312 created "2020-04-17" @default.
• W3015270312 creator A5000775867 @default.
• W3015270312 creator A5004870901 @default.
• W3015270312 creator A5014972181 @default.
• W3015270312 creator A5016361449 @default.
• W3015270312 creator A5016375050 @default.
• W3015270312 creator A5032655219 @default.
• W3015270312 creator A5042384048 @default.
• W3015270312 creator A5050043235 @default.
• W3015270312 creator A5052303539 @default.
• W3015270312 creator A5055105567 @default.
• W3015270312 creator A5057767046 @default.
• W3015270312 creator A5058710884 @default.
• W3015270312 creator A5060363731 @default.
• W3015270312 creator A5087533306 @default.
• W3015270312 date "2020-04-01" @default.
• W3015270312 modified "2023-10-15" @default.
• W3015270312 title "Development of Novel Mouse Monoclonal Antibodies Against Human CD19" @default.
• W3015270312 cites W1543988047 @default.
• W3015270312 cites W2031089532 @default.
• W3015270312 cites W2061728533 @default.
• W3015270312 cites W2086669738 @default.
• W3015270312 cites W2101882317 @default.
• W3015270312 cites W2104187048 @default.
• W3015270312 cites W2109440389 @default.
• W3015270312 cites W2115465690 @default.
• W3015270312 cites W2132658215 @default.
• W3015270312 cites W2144827965 @default.
• W3015270312 cites W2146993009 @default.
• W3015270312 cites W2157100766 @default.
• W3015270312 cites W2179454156 @default.
• W3015270312 cites W2546807589 @default.
• W3015270312 cites W2608673350 @default.
• W3015270312 cites W2756315669 @default.
• W3015270312 cites W2793168509 @default.
• W3015270312 cites W2796187715 @default.
• W3015270312 cites W2797047155 @default.
• W3015270312 cites W2800949131 @default.
• W3015270312 cites W2898145257 @default.
• W3015270312 cites W2900391822 @default.
• W3015270312 cites W33007984 @default.
• W3015270312 doi "https://doi.org/10.1089/mab.2020.0003" @default.
• W3015270312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32271687" @default.
• W3015270312 hasPublicationYear "2020" @default.
• W3015270312 type Work @default.
• W3015270312 sameAs 3015270312 @default.
• W3015270312 citedByCount "13" @default.
• W3015270312 countsByYear W30152703122020 @default.
• W3015270312 countsByYear W30152703122021 @default.
• W3015270312 countsByYear W30152703122022 @default.
• W3015270312 countsByYear W30152703122023 @default.
• W3015270312 crossrefType "journal-article" @default.
• W3015270312 hasAuthorship W3015270312A5000775867 @default.
• W3015270312 hasAuthorship W3015270312A5004870901 @default.
• W3015270312 hasAuthorship W3015270312A5014972181 @default.
• W3015270312 hasAuthorship W3015270312A5016361449 @default.
• W3015270312 hasAuthorship W3015270312A5016375050 @default.
• W3015270312 hasAuthorship W3015270312A5032655219 @default.
• W3015270312 hasAuthorship W3015270312A5042384048 @default.
• W3015270312 hasAuthorship W3015270312A5050043235 @default.
• W3015270312 hasAuthorship W3015270312A5052303539 @default.
• W3015270312 hasAuthorship W3015270312A5055105567 @default.
• W3015270312 hasAuthorship W3015270312A5057767046 @default.
• W3015270312 hasAuthorship W3015270312A5058710884 @default.
• W3015270312 hasAuthorship W3015270312A5060363731 @default.
• W3015270312 hasAuthorship W3015270312A5087533306 @default.
• W3015270312 hasConcept C147483822 @default.
• W3015270312 hasConcept C153911025 @default.
• W3015270312 hasConcept C159654299 @default.
• W3015270312 hasConcept C195616568 @default.
• W3015270312 hasConcept C203014093 @default.
• W3015270312 hasConcept C2778020697 @default.
• W3015270312 hasConcept C2778453870 @default.
• W3015270312 hasConcept C2778957590 @default.
• W3015270312 hasConcept C542903549 @default.
• W3015270312 hasConcept C552990157 @default.
• W3015270312 hasConcept C553184892 @default.
• W3015270312 hasConcept C55493867 @default.
• W3015270312 hasConcept C81089528 @default.
• W3015270312 hasConcept C86803240 @default.
• W3015270312 hasConceptScore W3015270312C147483822 @default.
• W3015270312 hasConceptScore W3015270312C153911025 @default.
• W3015270312 hasConceptScore W3015270312C159654299 @default.
• W3015270312 hasConceptScore W3015270312C195616568 @default.
• W3015270312 hasConceptScore W3015270312C203014093 @default.
• W3015270312 hasConceptScore W3015270312C2778020697 @default.
• W3015270312 hasConceptScore W3015270312C2778453870 @default.
• W3015270312 hasConceptScore W3015270312C2778957590 @default.
• W3015270312 hasConceptScore W3015270312C542903549 @default.
• W3015270312 hasConceptScore W3015270312C552990157 @default.
• W3015270312 hasConceptScore W3015270312C553184892 @default.
• W3015270312 hasConceptScore W3015270312C55493867 @default.
• W3015270312 hasConceptScore W3015270312C81089528 @default.
• W3015270312 hasConceptScore W3015270312C86803240 @default.
• W3015270312 hasIssue "2" @default.
• W3015270312 hasLocation W30152703121 @default.
• W3015270312 hasOpenAccess W3015270312 @default.

• next